Last reviewed · How we verify

NCT05600712

A Retro/Prospective Multi-Centre Data Capture on REDAPT Sleeved Stem

Completed NA Last updated 15 March 2024
What this trial tests

NA trial testing REDAPT Sleeved Stem in Safety and Performance in 45 participants. Completed in 14 February 2024.

Timeline
11 January 2022
Primary endpoint
14 February 2024
14 February 2024

Quick facts

Lead sponsorFoundation for Orthopaedic Research and Education
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment45
Start date11 January 2022
Primary completion14 February 2024
Estimated completion14 February 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Foundation for Orthopaedic Research and Education

Who can join

Eligibility, any sex, with Safety and Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retro/Prospective study to collect 2 year follow-up on REDAPT sleeved stem.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Safety and Performance

Currently open trials in the same condition.

Other Foundation for Orthopaedic Research and Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05600712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing